COMMUNIQUÉS West-GlobeNewswire
-
Medera Announces Independent Data Monitoring Committee (DMC) Recommends Continued Advancement of Lead HFpEF Gene Therapy Program
25/06/2026 -
Conexeu Sciences Opens Vancouver R&D Facility to Advance Regenerative Tissue Platform
25/06/2026 -
Aeroflow Health Acquires Canopie to Close the Maternal Care Gap for Millions of New Mothers
25/06/2026 -
Arrakis Therapeutics Announces CEO Transition with Mark DeLong Appointed as New CEO
25/06/2026 -
Evaluate Recognized for Artificial Intelligence Innovation in 9th Annual AI Breakthrough Awards Program
25/06/2026 -
Milestone Scientific Strengthens Board to Support Next Phase of Growth
25/06/2026 -
Eliaz Therapeutics Highlights Selective Galectin-3 Removal in Sepsis, Advances XGAL-3® Program
25/06/2026 -
La Croix-Rouge canadienne et Walmart Canada donnent le coup d’envoi à la campagne de financement annuelle
25/06/2026 -
Canadian Red Cross and Walmart Canada launch annual giving campaign
25/06/2026 -
Wandercraft Names National Seating & Mobility the Exclusive CRT Distribution Partner for Eve™ Personal Exoskeleton
25/06/2026 -
Survey Exposes a Crisis of Avoidance in Family Caregiving
25/06/2026 -
Daré Bioscience Highlights Revenue Opportunity as CEO Discusses Upcoming Launch of Flora Sync LF5™ in Virtual Investor “What This Means” Segment
25/06/2026 -
New PerfectServe Research: 85% of Healthcare Leaders Want to Switch Their Contact Center Vendors, But Most Feel Trapped
25/06/2026 -
The LaVie Institute Introduces Less-Invasive Breast Augmentation Technique with Rapid Recovery
25/06/2026 -
Ernexa Therapeutics Launches CEO Corner to Provide Deeper Insights into Company Progress, Scientific Strategy and Vision for Patients
25/06/2026 -
Helus Pharma™ Announces Closing of US$50 Million Underwritten Offering
25/06/2026 -
Psychedelic Science 2027 Speaker Submission Invites the Field to Bridge Promise and Practice
25/06/2026 -
EMBARC Announces Its Intention to Collaborate with Insmed on Landmark Interventional Study Evaluating Disease Modification Potential of Brensocatib in Bronchiectasis
25/06/2026 -
AtaiBeckley to Join the Russell Indexes, Expanding Visibility Across U.S. Equity Markets
25/06/2026
Pages